Structure Therapeutics Inc. - Ordinary Shares, par value $0.0001 per share (GPCR)

Q: What does CUSIP 86366E106 represent in this 13F holders report?

CUSIP 86366E106 is the security identifier for GPCR - Structure Therapeutics Inc. - Ordinary Shares, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held GPCR - Structure Therapeutics Inc. - Ordinary Shares, par value $0.0001 per share in Q3 2023?

83 institutional investors reported GPCR - Structure Therapeutics Inc. - Ordinary Shares, par value $0.0001 per share for Q3 2023. Use the holders table for investor-level position and value details.

CUSIP: 86366E106

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class: Equity / Ordinary Shares, par value $0.0001 per share
Shares outstanding: 213,001,347
Total 13F shares: 32,752,287
Share change: +15,009,176
Total reported value: $1,641,782,565
Price per share: $50.42
Number of holders: 83
Value change: +$750,250,715
Number of buys: 70
Number of sells: 12

Quarterly Holders Quick Answers

What is CUSIP 86366E106?
CUSIP 86366E106 identifies GPCR - Structure Therapeutics Inc. - Ordinary Shares, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2023
Previous quarter: Q2 2023

Recent filing periods for CUSIP 86366E106:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Institutional Holders of Structure Therapeutics Inc. - Ordinary Shares, par value $0.0001 per share (GPCR) as of Q3 2023

As of 30 Sep 2023, Structure Therapeutics Inc. - Ordinary Shares, par value $0.0001 per share (GPCR) was held by 83 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 32,752,287 shares. The largest 10 holders included PRICE T ROWE ASSOCIATES INC /MD/, Driehaus Capital Management LLC, JANUS HENDERSON GROUP PLC, Deep Track Capital, LP, ADAGE CAPITAL PARTNERS GP, L.L.C., BVF INC/IL, FMR LLC, T. Rowe Price Investment Management, Inc., TCG Crossover Management, LLC, and Casdin Capital, LLC. This page lists 83 institutional shareholders reporting positions in this security for the Q3 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.